ONCOLOGY VENTURE A/S

Inactive Instrument

Transcripts Oncology Venture A/S Nasdaq Stockholm

Equities

End-of-day quote Nasdaq Stockholm Other stock markets
- ^SEK	-

24/05	Allarity Therapeutics, Inc. Concludes Its Phase 2 Clinical Trial	CI
06/05	Allarity Therapeutics Says Stockholders' Equity 'Significantly' Exceeds Nasdaq's $2.5 Million Minimum Rule	MT

Transcripts

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Transcript : Allarity Therapeutics, Inc. - Shareholder/Analyst Call	01/04
Transcript : Allarity Therapeutics, Inc. - Shareholder/Analyst Call	23/23/23
Transcript : Allarity Therapeutics, Inc. - Shareholder/Analyst Call	20/23/20
Transcript : Allarity Therapeutics, Inc. - Shareholder/Analyst Call	03/23/03
Transcript : Allarity Therapeutics A/S - Shareholder/Analyst Call	22/21/22
Transcript : Allarity Therapeutics A/S - Shareholder/Analyst Call	31/21/31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer